It is owned and operated by the Chiefs Development Group. Prospera Centre includes a main arena with a seating capacity of 5,000. The second arena is designed for community use and accommodates approximately 300 seats.
Breo Ellipta is a prescription medication used to decrease lung inflammation and open its passageways. It is a combination of fluticasone and vilanterol and comes in two strengths, 100mcg/25mcg and 200mcg/25mcg (fluticasone/vilanterol), with prices for one inhaler with sixty blisters ranging from $290 to $380.
The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.